Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (3): 453-460    DOI: 10.31083/j.ceog.2021.03.2442
Special Issue: New Frontiers and Updates in the Diagnosis and Treatment of Female Infertility
Review | Next articles
Fertility options in Mayer-Rokitansky-Küster-Hauser syndrome
Francesco Fedele1, *(), Alessandro Bulfoni2, Stefano Salvatore1, Massimo Candiani1
1Obstetrics and Gynaecology Department, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
2Department of Gynaecology, Division of Obstetrics and Gynaecology, IRCCS Humanitas Clinical and Research Center, San Pio X, 20089 Milan, Italy
Download:  PDF(738KB)  ( 137 ) Full text   ( 23 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: The Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome is the most common cause of uterine aplasia, with a worldwide frequency of 1 in 4500 females. Although abundant literature is present regarding the different available methods for creating a neovagina in MRKH syndrome, the attention dedicated to these women's reproductive potential remains insufficient. Methods: Online searches were carried out in PubMed database during November and December 2020. The search included a combination of the various terms (e.g., MRKH, vaginoplasty, uterus transplantation, infertility treatment, gestational surrogacy, etc.). The following inclusion criteria were used: (1) The articles should be written in English or French language. (2) The article should have been published by an official scientific organization. Results: Until few years ago, the only option for women with MRKH syndrome was legal adoption, now gestational surrogacy (GS) and uterine transplantation (UTx) have become new fertility options available to these patients. Discussion: GS is officially recognized in several countries and widely practiced. On the other hand, UTx, although the great recent technical improvements, is far from being an option for all women with MRKH syndrome secondary to its complexity and the necessary immunologic therapies.
Key words:  Mayer-Rokitansky-Küster-Hauser syndrome      Assisted reproductive technology      Gestational surrogacy      Uterus transplantation     
Submitted:  31 December 2020      Revised:  16 February 2021      Accepted:  24 February 2021      Published:  15 June 2021     
*Corresponding Author(s):  Francesco Fedele     E-mail:  francesco.fedele123@gmail.com

Cite this article: 

Francesco Fedele, Alessandro Bulfoni, Stefano Salvatore, Massimo Candiani. Fertility options in Mayer-Rokitansky-Küster-Hauser syndrome. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 453-460.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.03.2442     OR     https://ceog.imrpress.com/EN/Y2021/V48/I3/453

[1] Banuhan Şahin, Buğra Şahin, Pervin Karlı, Görker Sel, Şafak Hatırnaz, Osman Fadıl Kara, Andrea Tinelli. Level of depression and hopelessness among women with infertility during the outbreak of COVID-19: a cross-sectional investigation[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 594-600.
[2] Dino Pavoković, Vesna Elveđi Gašparović, Tvrtko Tupek, Analena Gregorić, Ana Tikvica Luetić, Dubravko Habek. Perinatal outcome in twins. A hospital based comparative study at a single third-level care centre in Croatia[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 631-636.
No Suggested Reading articles found!